{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T05:03:35Z","timestamp":1769317415468,"version":"3.49.0"},"reference-count":28,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2021,6,15]]},"abstract":"<jats:p>The aim of the present study was to determine and compare the concentration of hyaluronic acid (HA) in rheumatoid arthritis (RA), systemic sclerosis (SSc) and systemic lupus erythematosus (SLE), and its correlation with parameters of disease activity and duration. The hypothesis was that HA should be increased in rheumatic diseases. We also expected that HA could be a marker of disease activity and inflammation in some of these diseases.\nThe study group comprised 149 patients with RA, SSc and SLE hospitalized in the Department of Rheumatology and Internal Diseases, Medical University of Bialystok (Bialystok, Poland) and 30 healthy controls. The concentrations of HA, C-reactive protein (CRP) and rheumatoid factor (RF) were measured using Architect ci8200; haemoglobin, platelets on Sysmex XS-800i; and erythrocyte sedimentation rate (ESR) on Sediplus S 2000 analysers. Statistical analysis was performed using Statistica 13.3 PL.\nHyaluronic acid was increased in RA, SLE and SSc when compared to controls (P &lt; 0.001, P = 0.011, and P = 0.015, respectively). There were no differences in HA between rheumatic diseases (P = 0.840). Hyaluronic acid positively correlated with SLE activity (P = 0.025). In RA, HA positively correlated with ESR (P = 0.028) and CRP (P = 0.009). However, HA was not found to correlate with the duration of rheumatic diseases.\nHyaluronic acid concentration undergoes changes in rheumatic diseases with no difference between RA, SLE and SSc. In RA, HA concentration can be a marker of inflammation, while in SLE patients an indicator of disease activity.<\/jats:p>","DOI":"10.11613\/bm.2021.020701","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T11:18:54Z","timestamp":1618399134000},"page":"240-249","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus"],"prefix":"10.11613","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9890-7334","authenticated-orcid":false,"given":"Bogdan","family":"Cylwik","sequence":"first","affiliation":[{"name":"Department of Pediatric Laboratory Diagnostics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Gruszewska","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Gindzienska-Sieskiewicz","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Internal Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otylia","family":"Kowal-Bielecka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Internal Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lech","family":"Chrostek","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4885","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"key20210414071659_r1"},{"issue":"5","key":"key20210414071659_r2","first-page":"S54","article-title":"Biochemical markers of joint tissue turnover in early rheumatoid arthritis.","volume":"21","author":"Garnero","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"key20210414071659_r3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/ar3280","article-title":"Biochemical markers of ongoing joint damage in rheumatoid arthritis \u2013 current and future applications, limitations and opportunities.","volume":"13","author":"Karsdal","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"key20210414071659_r4","first-page":"S247","article-title":"Increased serum hyaluronic acid levels in rheumatoid arthritis.","volume":"37","author":"Santos","year":"1994","journal-title":"Arthritis Rheum"},{"key":"key20210414071659_r5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.1997.00170.x","article-title":"Hyaluronian: its nature, distribution, functions and turnover.","volume":"242","author":"Fraser","year":"1997","journal-title":"J Intern Med"},{"key":"key20210414071659_r6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/07853899609033126","article-title":"Serum hyaluronian as a disease marker.","volume":"28","author":"Laurent","year":"1996","journal-title":"Ann Med"},{"key":"key20210414071659_r7","first-page":"974","article-title":"Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.","volume":"23","author":"Emlen","year":"1996","journal-title":"J Rheumatol"},{"key":"key20210414071659_r8","first-page":"1825","article-title":"Clinical significance of serum hyaluronian levels in systemic sclerosis: association with disease severity.","volume":"35","author":"Yoshizaki","year":"2008","journal-title":"J Rheumatol"},{"key":"key20210414071659_r9","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/ard.2003.010942","article-title":"Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis.","volume":"63","author":"Majeed","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"key20210414071659_r10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1369\/0022155410398000","article-title":"Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythrematosus and dermatomyositis.","volume":"59","author":"Chang","year":"2011","journal-title":"J Histochem Cytochem"},{"key":"key20210414071659_r11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/36.11.1161","article-title":"Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: relationship to development of joint destruction in hands and feet.","volume":"36","author":"Fex","year":"1997","journal-title":"Br J Rheumatol"},{"key":"key20210414071659_r12","first-page":"752","article-title":"Increased levels of circulating hyaluronate in the sera of patients with rheumatoid arthritis with special reference to joint destruction.","volume":"34","author":"Yamada","year":"1994","journal-title":"Ryumachi"},{"key":"key20210414071659_r13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.13005\/bpj\/903","article-title":"Rheumatoid arthritis: hyaluronic acid and cartilage oligomeric matrix protein as predictors of the disease progression.","volume":"9","author":"Al-Dalaen","year":"2016","journal-title":"Biomed Pharmacol J"},{"issue":"4","key":"key20210414071659_r14","first-page":"S3","article-title":"Systemic sclerosis: a critical digest of the recent literature.","volume":"33","author":"Barsotti","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"key20210414071659_r15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.17221\/1930-VETMED","article-title":"Hyaluronic acid (hyaluronian): a review.","volume":"53","author":"Necas","year":"2008","journal-title":"Vet Med"},{"key":"key20210414071659_r16","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative.","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20210414071659_r17","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis.","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"key20210414071659_r18","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"key":"key20210414071659_r19","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus.","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"key20210414071659_r20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on prognosis studies in SLE.","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"key20210414071659_r21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(90)90005-D","article-title":"Serum baseline hyaluronate and disease activity in rheumatoid arthritis.","volume":"193","author":"Konttinen","year":"1990","journal-title":"Clin Chim Acta"},{"key":"key20210414071659_r22","first-page":"98","article-title":"Serum hyaluronic acid and amino terminal procollagen III peptide in inflammatory and degenerative joint diseases.","volume":"47","author":"Seibel","year":"1988","journal-title":"Z Rheumatol"},{"key":"key20210414071659_r23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.1780301203","article-title":"Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients: relationship to synovitis mass and morning stiffness.","volume":"30","author":"Engstr\u00f6m-Laurent","year":"1987","journal-title":"Arthritis Rheum"},{"key":"key20210414071659_r24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/art.1780330605","article-title":"Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratin sulfate.","volume":"33","author":"Poole","year":"1990","journal-title":"Arthritis Rheum"},{"key":"key20210414071659_r25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000246314","article-title":"Hyaluronic acid in progressive systemic sclerosis.","volume":"192","author":"Freitas","year":"1996","journal-title":"Dermatology"},{"key":"key20210414071659_r26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03009749209095054","article-title":"Serum levels of aminoterminal type III procollagen peptide and hyaluronian predict mortality in systemic sclerosis.","volume":"21","author":"Scheja","year":"1992","journal-title":"Scand J Rheumatol"},{"key":"key20210414071659_r27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2133.1991.tb00619.x","article-title":"Clinical correlations and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis.","volume":"124","author":"Levesque","year":"1991","journal-title":"Br J Dermatol"},{"key":"key20210414071659_r28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/ard.44.9.614","article-title":"Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells?","volume":"44","author":"Engstr\u00f6m-Laurent","year":"1985","journal-title":"Ann Rheum Dis"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/31\/2\/10.11613\/BM.2021.020701\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T15:22:17Z","timestamp":1626708137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/31\/2\/10.11613\/BM.2021.020701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6,15]]},"published-print":{"date-parts":[[2021,6,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2021.020701","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}